Delivery Order SPE2DB25D3018-SPE2DB25FUYDG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency (DLA) awarded a $2,435.84 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin on September 23, 2025, with completion expected by September 24, 2025. This firm fixed-price contract represents a single delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.03 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL 3 mL insulin, with an ultimate completion date of August 6, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a single transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $4,450.76 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This non-competitive delivery order, issued on May 8, 2025, with an ultimate completion date of May 9, 2025, represents a firm fixed price transaction for pharmaceutical supply. The award was fulfilled by AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency has awarded a delivery order valued at $1,965.00 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the company is headquartered. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,889.55 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL cartridges. This firm fixed-price delivery order, which is non-competitive set-aside, is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,738.76 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin, with an ultimate completion date of August 28, 2025. This non-competitive delivery order was issued under a firm fixed price arrangement, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a routine pharmaceutical procurement action...
- The Defense Logistics Agency awarded a delivery order valued at $2,006.73 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and utilizes firm fixed price pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin on August 5, 2025, with completion scheduled for August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYDGDelivery Order
The Defense Logistics Agency awarded a $1,968.89 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a wide range of medications and medical supplies to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's track record demonstrates consistent capability in fulfilling federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/4/25 |